UBS Group’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Sell |
109,959
-57,947
| -35% | -$110K | ﹤0.01% | 5455 |
|
|
2025
Q1 | $1.19M | Buy |
167,906
+137,137
| +446% | +$971K | ﹤0.01% | 4064 |
|
|
2024
Q4 | $678K | Buy |
30,769
+22,065
| +254% | +$486K | ﹤0.01% | 4508 |
|
|
2024
Q3 | $175K | Buy |
8,704
+6,636
| +321% | +$133K | ﹤0.01% | 4799 |
|
|
2024
Q2 | $36K | Sell |
2,068
-2,235
| -52% | -$38.9K | ﹤0.01% | 5793 |
|
|
2024
Q1 | $179K | Buy |
4,303
+4,262
| +10,395% | +$178K | ﹤0.01% | 4788 |
|
|
2023
Q4 | $1.03K | Sell |
41
-4,717
| -99% | -$118K | ﹤0.01% | 7213 |
|
|
2023
Q3 | $156K | Buy |
4,758
+4,674
| +5,564% | +$153K | ﹤0.01% | 4432 |
|
|
2023
Q2 | $4.9K | Sell |
84
-3,249
| -97% | -$189K | ﹤0.01% | 6411 |
|
|
2023
Q1 | $87K | Buy |
+3,333
| New | +$87K | ﹤0.01% | 4952 |
|
|
2022
Q4 | – | Sell |
-318
| Closed | -$16K | – | 9854 |
|
|
2022
Q3 | $16K | Buy |
318
+277
| +676% | +$13.9K | ﹤0.01% | 6622 |
|
|
2022
Q2 | $1K | Sell |
41
-1
| -2% | -$24 | ﹤0.01% | 8937 |
|
|
2022
Q1 | $2K | Buy |
42
+20
| +91% | +$952 | ﹤0.01% | 8623 |
|
|
2021
Q4 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 8709 |
|
|
2021
Q3 | – | Sell |
-4
| Closed | -$1K | – | 8829 |
|
|
2021
Q2 | $1K | Sell |
4
-129
| -97% | -$32.3K | ﹤0.01% | 8084 |
|
|
2021
Q1 | $34K | Sell |
133
-381
| -74% | -$97.4K | ﹤0.01% | 5894 |
|
|
2020
Q4 | $99K | Buy |
514
+142
| +38% | +$27.4K | ﹤0.01% | 4714 |
|
|
2020
Q3 | $75K | Buy |
372
+202
| +119% | +$40.7K | ﹤0.01% | 4526 |
|
|
2020
Q2 | $48K | Sell |
170
-139
| -45% | -$39.2K | ﹤0.01% | 5060 |
|
|
2020
Q1 | $93K | Sell |
309
-180
| -37% | -$54.2K | ﹤0.01% | 4488 |
|
|
2019
Q4 | $157K | Buy |
489
+187
| +62% | +$60K | ﹤0.01% | 4742 |
|
|
2019
Q3 | $115K | Buy |
302
+260
| +619% | +$99K | ﹤0.01% | 4771 |
|
|
2019
Q2 | $19K | Buy |
42
+36
| +600% | +$16.3K | ﹤0.01% | 5783 |
|
|
2019
Q1 | $3K | Sell |
6
-33
| -85% | -$16.5K | ﹤0.01% | 6515 |
|
|
2018
Q4 | $16K | Buy |
39
+20
| +105% | +$8.21K | ﹤0.01% | 6032 |
|
|
2018
Q3 | $5K | Sell |
19
-77
| -80% | -$20.3K | ﹤0.01% | 6587 |
|
|
2018
Q2 | $63K | Sell |
96
-23
| -19% | -$15.1K | ﹤0.01% | 4925 |
|
|
2018
Q1 | $491K | Buy |
119
+1
| +0.8% | +$4.13K | ﹤0.01% | 3480 |
|
|
2017
Q4 | $270K | Buy |
+118
| New | +$270K | ﹤0.01% | 3835 |
|